HCV replication inhibitors (Chinese Academy of Medical Sciences & Peking Union Medical College)

N/A

Report date: 2025/03/20 15:18:57
NME

Base Information

Drug NameHCV replication inhibitors (Chinese Academy of Medical Sciences & Peking Union Medical College)
Drug Alias Namecajanine
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis C virus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChinese Academy Of Medical Science & Peking Union Medical College
China Registration ClassN/A

Develop Information

Active CompaniesChinese Academy Of Medical Science & Peking Union Medical College
Inactive CompaniesN/A
Active IndicationsHepatitis C
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A